• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Treatment of hypoparathyroid patients with chlorthalidone.

作者信息

Porter R H, Cox B G, Heaney D, Hostetter T H, Stinebaugh B J, Suki W N

出版信息

N Engl J Med. 1978 Mar 16;298(11):577-81. doi: 10.1056/NEJM197803162981101.

DOI:10.1056/NEJM197803162981101
PMID:628374
Abstract

In an effort to maintain normal serum calcium levels without inducing hypercalciuria, we treated seven hypoparathyroid patients for up to 25 months with chlorthalidone, a thiazide-like sulfonamide diuretic, plus a salt-restricted diet, without added vitamin D. Mean 24-hour calcium excretion decreased from 179 to 88 mg (P less than 0.001), and mean serum calcium increased from 8.2 to 9.3 mg per deciliter (P less than 0.05). Diuretic therapy or moderate salt restriction alone was not as effective as combined therapy. Beneficial effects were sustained for as long as therapy was maintained. The rise in serum calcium, which involves the filterable and ionized fractions, cannot be due entirely to reduced excretion and may in part be explained by increased intestinal absorption. Oral chlorthalidone plus a low salt diet appears to be an effective alternative to vitamin D in the maintenance therapy of at least some patients with hypoparathyroidism.

摘要

相似文献

1
Treatment of hypoparathyroid patients with chlorthalidone.
N Engl J Med. 1978 Mar 16;298(11):577-81. doi: 10.1056/NEJM197803162981101.
2
[The effect of chlorthalidone (Hygroton) on the urinary elimination of phosphorus and the amount of phosphorus in the blood in hypoparathyroid and normal subjects].[氯噻酮(海吉妥)对甲状旁腺功能减退和正常受试者尿磷排泄及血磷含量的影响]
Schweiz Med Wochenschr. 1965 Dec 11;95(50):1706-14.
3
Effects of moderate salt restriction in hypertensive patients treated with oxprenolol or chlorthalidone.适度限盐对用氧烯洛尔或氯噻酮治疗的高血压患者的影响。
Int J Clin Pharmacol Ther Toxicol. 1984 Aug;22(8):451-5.
4
Oral magnesium load test for the assessment of intestinal magnesium absorption. Application in control subjects, absorptive hypercalciuria, primary hyperparathyroidism, and hypoparathyroidism.用于评估肠道镁吸收的口服镁负荷试验。在对照受试者、吸收性高钙尿症、原发性甲状旁腺功能亢进症和甲状旁腺功能减退症中的应用。
Miner Electrolyte Metab. 1982 Jul;8(1):44-51.
5
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
6
Transient hypoparathyroidism during acute alcohol intoxication.急性酒精中毒期间的短暂性甲状旁腺功能减退
N Engl J Med. 1991 Mar 14;324(11):721-7. doi: 10.1056/NEJM199103143241103.
7
Use of thiazide diuretics to reduce the hypercalciuria of hypoparathyroidism during pregnancy.使用噻嗪类利尿剂降低妊娠期甲状旁腺功能减退症的高钙尿症。
Am J Perinatol. 1990 Oct;7(4):333-6. doi: 10.1055/s-2007-999516.
8
Hypocalciuric effect of chlorthalidone in two hypoparathyroid children.氯噻酮对两名甲状旁腺功能减退儿童的降钙尿作用。
Helv Paediatr Acta. 1986 Dec;41(5):465-7.
9
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).血管紧张素转换酶抑制剂或钙通道阻滞剂与利尿剂治疗高危高血压患者的肾脏转归:抗高血压和降脂治疗预防心脏病发作试验(ALLHAT)报告
Arch Intern Med. 2005 Apr 25;165(8):936-46. doi: 10.1001/archinte.165.8.936.
10
changes in serum and urinary calcium during treatment with hydrochlorothiazide: studies on mechanisms.氢氯噻嗪治疗期间血清和尿钙的变化:作用机制研究
J Clin Invest. 1972 Apr;51(4):945-54. doi: 10.1172/JCI106889.

引用本文的文献

1
Hypoparathyroidism: diagnosis, management and emerging therapies.甲状旁腺功能减退症:诊断、管理及新出现的治疗方法。
Nat Rev Endocrinol. 2025 Jun;21(6):360-374. doi: 10.1038/s41574-024-01075-8. Epub 2025 Feb 4.
2
[Review of clinical practice guidelines for hypoparathyroidism].[甲状旁腺功能减退症临床实践指南综述]
Probl Endokrinol (Mosk). 2021 Aug 17;67(4):68-83. doi: 10.14341/probl12800.
3
A case report of T-box 1 mutation causing phenotypic features of chromosome 22q11.2 deletion syndrome.一例由T-box 1突变导致22q11.2缺失综合征表型特征的病例报告。
Clin Diabetes Endocrinol. 2019 Aug 13;5:13. doi: 10.1186/s40842-019-0087-6. eCollection 2019.
4
MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders.内分泌疾病管理:甲状旁腺疾病治疗、教育和科学方面的未满足需求。
Eur J Endocrinol. 2019 Sep 1;181(3):P1-P19. doi: 10.1530/EJE-19-0316. Epub 2019 Jun 1.
5
Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus.成人甲状旁腺功能减退症的护理标准:加拿大与国际共识
Eur J Endocrinol. 2019 Mar;180(3):P1-P22. doi: 10.1530/EJE-18-0609.
6
Management of Hypoparathyroidism: Present and Future.甲状旁腺功能减退症的管理:现状与未来
J Clin Endocrinol Metab. 2016 Jun;101(6):2313-24. doi: 10.1210/jc.2015-3910. Epub 2016 Mar 3.
7
Long-term follow-up of patients with hypoparathyroidism.甲状旁腺功能减退症患者的长期随访。
J Clin Endocrinol Metab. 2012 Dec;97(12):4507-14. doi: 10.1210/jc.2012-1808. Epub 2012 Oct 5.
8
Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.成人甲状旁腺功能减退症:流行病学、诊断、病理生理学、靶器官受累、治疗以及未来研究的挑战。
J Bone Miner Res. 2011 Oct;26(10):2317-37. doi: 10.1002/jbmr.483.
9
Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats.氯噻酮可改善遗传性高钙尿结石形成大鼠的椎骨骨质量。
J Bone Miner Res. 2011 Aug;26(8):1904-12. doi: 10.1002/jbmr.374.
10
Primary hyperparathyroidism and thiazide diuretics.原发性甲状旁腺功能亢进症与噻嗪类利尿剂
Postgrad Med J. 1981 Feb;57(664):80-3. doi: 10.1136/pgmj.57.664.80.